Immatics N.V (IMTX) has a profit margin of -480.39%, below the Healthcare sector average of 13.76%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Immatics N.V (IMTX) currently reports a profit margin of -480.39% as of June 2026. That compares with -56.8% in the prior-year period — down 745.8% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Immatics N.V's profit margin history and peer comparisons.
Immatics N.V's profit margin decreased from -56.8% to -480.39% — a 745.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Immatics N.V's profit margin of -480.39% is lower than the Healthcare sector average of 13.76%. That is roughly 3591.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Immatics N.V's current -480.39% should be judged against Healthcare norms (sector average: 13.76%) and against IMTX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -480.39%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Immatics N.V, and consider following IMTX for alerts when major investors trade the stock.